Screening for rare variants in the coding region of ALS-associated genes at 9p21.2 and 19p13.3

Neurobiology of Aging

Volumn 34, Issue 5, 2013, Pages 1518.e5-1518.e7

  Koppers, Max ^a   Groen, Ewout J N ^a   van Vught, Paul W J ^a   van Rheenen, Wouter ^a   Witteveen, Esther ^a   van Es, Michael A ^a   Pasterkamp, R Jeroen ^a   van den Berg, Leonard H ^a   Veldink, Jan H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; C9ORF72; Genetics; Genome wide association studies; Mutation analysis; UNC13A

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; C9ORF72 GENE; CHROMOSOME 5; CHROMOSOME 9; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE; GENE FUNCTION; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IFNK GENE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOBKL2B GENE; NONSENSE MUTATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; UNC13A GENE;

EID: 84873446085     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.09.018     Document Type: Article

References (15)

1. Bansal V., Libiger O., Torkamani A., Schork N.J. Statistical analysis strategies for association studies involving rare variants. Nat. Rev. Genet. 2010, 11:773-785.
2. Dejesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y.R., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
3. Diekstra F.P., van Vught P.W., van Rheenen W., Koppers M., Pasterkamp R.J., van Es M.A., Schelhaas H.J., de Visser M., Robberecht W., van Damme P., Andersen P.M., van den Berg L.H., Veldink J.H. UNC13A is a modifier of survival in amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33:630.e3-630.e8.
4. Dion P.A., Daoud H., Rouleau G.A. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat. Rev. Genet. 2009, 10:769-782.
5. Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet 2011, 377:942-955.
6. Koppers M., van Es M., van den Berg L.H., Veldink J.H., Pasterkamp R.J. Genetics of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 2012, 479-516. InTech, New York, NY. M. Maurer (Ed.).
7. Laaksovirta H., Peuralinna T., Schymick J.C., Scholz S.W., Lai S.-L., Myllykangas L., Sulkava R., Jansson L., Hernandez D.G., Gibbs J.R., Nalls M.A., Heckerman D., Tienari P.J., Traynor B.J. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol. 2010, 9:978-985.
8. Madsen B.E., Browning S.R. A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet. 2009, 5:e1000384.
9. Majounie E., Renton A.E., Mok K., Dopper E.G.P., Waite A., Rollinson S., Chiò A., Restagno G., Nicolaou N., Simon-Sanchez J., van Swieten J.C., Abramzon Y., Johnson J.O., Sendtner M., Pamphlett R., Orrell R.W., Mead S., Sidle K.C., Houlden H., Rohrer J.D., Morrison K.E., Pall H., Talbot K., Ansorge O., The Chromosome 9-ALS/FTD Consortium, The French research network on FTLD/ALS, The ITALSGEN Consortium, Hernandez D.G., Arepalli S., Sabatelli M., Mora G., Corbo M., Giannini F., Calvo A., Englund E., Borghero G., Floris G.L., Remes A.M., Laaksovirta H., McCluskey L., Trojanowski J.Q., Van Deerlin V.M., Schellenberg G.D., Nalls M.A., Drory V.E., Lu C.-S., Yeh T.-H., Ishiura H., Takahashi Y., Tsuji S., Le Ber I., Brice A., Drepper C., Williams N., Kirby J., Shaw P., Hardy J., Tienari P.J., Heutink P., Morris H.R., Pickering-Brown S., Traynor B.J. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012, 11:323-330.
10. Price A.L., Kryukov G.V., de Bakker P.I., Purcell S.M., Staples J., Wei L.J., Sunyaev S.R. Pooled association tests for rare variants in exon-resequencing studies. Am. J. Hum. Genet. 2010, 86:832-838.
11. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetu A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorrine A.L., Hölttä-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chio A., Restagno G., Borghero G., Sabatelli M., The ITALSGEN Consortium, Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268.
12. Shatunov A., Mok K., Newhouse S., Weale M.E., Smith B., Vance C., Johnson L., Veldink J.H., van Es M.A., van den Berg L.H., Robberecht W., Van Damme P., Hardiman O., Farmer A.E., Lewis C.M., Butler A.W., Abel O., Andersen P.M., Fogh I., Silani V., Chiò A., Traynor B.J., Melki J., Meininger V., Landers J.E., McGuffin P., Glass J.D., Pall H., Leigh P.N., Hardy J., Brown R.H., Powell J.F., Orrell R.W., Morrison K.E., Shaw P.J., Shaw C.E., Al-Chalabi A. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol. 2010, 9:986-994.
13. van Boxtel R., Toonen P.W., Verheul M., van Roekel H.S., Nijman I.J., Guryev V., Cuppen E. Improved generation of rat gene knockouts by target-selected mutagenesis in mismatch repair-deficient animals. BMC Genomics 2008, 9:460.
14. van Es M.A., Dahlberg C., Birve A., Veldink J.H., van den Berg L.H., Andersen P.M. Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 2010, 81:562-566.
15. van Es M.A., Veldink J.H., Saris C.G., Blauw H.M., van Vught P.W., Birve A., Lemmens R., Schelhaas H.J., Groen E.J., Huisman M.H., van der Kooi A.J., de Visser M., Dahlberg C., Estrada K., Rivadeneira F., Hofman A., Zwarts M.J., van Doormaal P.T., Rujescu D., Strengman E., Giegling I., Muglia P., Tomik B., Slowik A., Uitterlinden A.G., Hendrich C., Waibel S., Meyer T., Ludolph A.C., Glass J.D., Purcell S., Cichon S., Nöthen M.M., Wichmann H.E., Schreiber S., Vermeulen S.H., Kiemeney L.A., Wokke J.H., Cronin S., McLaughlin R.L., Hardiman O., Fumoto K., Pasterkamp R.J., Meininger V., Melki J., Leigh P.N., Shaw C.E., Landers J.E., Al-Chalabi A., Brown R.H., Robberecht W., Andersen P.M., Ophoff R.A., van den Berg L.H. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet. 2009, 41:1083-1087.